Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-1754
Title: Tissue Engineering - the gateway to regenerative medicine
Authors : Bono, Epifania
Mathes, Stephanie H
Franscini, Nicola
Graf-Hausner, Ursula
Published in : Chimia
Volume(Issue) : 64
Issue : 11
Pages : 808
Pages to: 812
Editors of the parent work: Alexakis, Domenico P.
Publisher / Ed. Institution : Schweizerische Chemische Gesellschaft
Publisher / Ed. Institution: Bern
Issue Date: Nov-2010
License (according to publishing contract) : Licence according to publishing contract
Type of review: Peer review (Publication)
Language : English
Subjects : Icbc; Automation; Biomaterials; Disc regeneration; Soft tissue; Tissue regeneration
Subject (DDC) : 616: Internal medicine and diseases
Abstract: Tissue Engineering as an emerging biotechnology sector aims at the in vitro regeneration of diseased tissues and promises to profoundly change medical practice, offering the possibility of regenerating tissues and organs instead of just repairing them (regenerative medicine). Improved healing processes and a higher quality of life are the expected results. This article gives an overview of different technologies for regenerative medicine and presents results of our own current applied research and development. A recent project was successfully closed with the development of a natural biomaterial for soft tissue oral defects. The establishment of an in vitro bioreactor system enabled us to simulate the mechanical and biological environment in a healing wound and to investigate the suitability of different implant materials for the oral tissue regeneration. Moreover, focusing the attention on an alternative method for the intervertebral disc (IVD) regeneration, we established a new tissue engineered approach, based on the three-dimensional (3D) culture of autologous human IVD cells into a polyurethane (PU)-fibrin composite. IVD cells were able to proliferate and, thanks to the 3D conditions, to differentiate expressing the typical native tissue markers. The development of an automated platform was the goal of an additional project, to standardize the cell culture technology, increase the bio-safety and reduce the production costs, moving tissue engineering nearer to clinical application.
Departement: Life Sciences und Facility Management
Organisational Unit: Institute of Chemistry and Biotechnology (ICBT)
Publication type: Article in scientific Journal
DOI : 10.2533/chimia.2010.808
10.21256/zhaw-1754
ISSN: 0009-4293
URI: https://digitalcollection.zhaw.ch/handle/11475/3295
Appears in Collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
2010_Bono_Tissue Engineering_Chimia.pdf630.92 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.